Healthcare Platform Curofy launches Chat feature to help Doctors discuss Real-Time Cases

Curofy, a leading healthcare networking application for doctors has launched ‘Curofy Chat’ feature. The new feature offers a fast and simple messaging service where doctors can chat with his/her fellow doctors and also can share /answer medical cases at the same time. Not only this, one can chat with hospital members and even discuss cases in group.

Curofy is a mobile app that facilitates interaction between doctors from various fields of medicine. With this platform, doctors can quickly locate other physicians, call them, take the second opinion, and seek advice on patient cases through collaboration. It’s an innovative platform for doctors to discover a solution for all their medical prerequisites with just a single click.

The main aim behind the chat feature is to provide a platform for doctors for immediate diagnosis. A survey was conducted on around 4,00,000 doctors where more than 85 % doctors were in favour that Curofy has become a problem-solving platform for them especially in the rural areas where the doctor count is less. Also, with the help of this, doctors can communicate at a faster way using the new innovation in the medical world.



Curofy Chat helps to discuss clinical cases in real time, create private chat room for doctors, connect without sharing the contact, one can form the professional multi-speciality groups and also robust communication. Discussion about problems in such groups can help to reduce the time of consultation and treatment. When doctor is in doubt about any case, he/she can easily get second opinion from his/her choice of doctor in the private chat as well.

Speaking about the feature, Mr. Pawan Gupta, Co-Founder, Curofy, "The chat feature transforms Curofy from being a knowledge sharing platform to an immediate diagnosis platform. This truly has the potential of disrupting doctors' day to day life in a good way. This is one of our biggest launch since our inception.”

Keeping into consideration, the demand and needs of doctors, the chat feature is acting as a new gadget for the members. Not like the other social application, Curofy Chat is specifically dedicated for the medical professional who wants to be in touch with more people and wants to learn more.

Curofy is a doctors’ networking platform which creates a spam-free and secure environment to communicate with each other. With more than 4,00,000 doctors on its platform, Curofy helps to solve more than 400 cases every day. With 4,00,000 cases solved so far, Curofy is indeed the biggest digital repository of patient case in the country. Now, with this ‘Chat’ feature, they are going to help the doctors with better and faster communication.

Gurgaon-based Curofy's Investor Buys The Startup From Its Founders

Gurgaon-based doctor networking platform Curofy has been sold out to its investor RoundGlass Partners LLC, from which the startup had raised undisclosed amount of funding in 2016. RoundGlass Partners has now took over Curofy approximately two years after the investment, reported VCCircle, citing two people aware of the development.

The report further said that the parent company of Curofy, 911 India Healthcare Pvt. Ltd, has been sold to RoundGlass in an all-cash deal worth $9-12 million (Rs 60-80 crore).

Founded in 2015 by IIT-Delhi alumni -- Mudit Vijayvergiya, Nipun Goyal and Pawan Gupta, Curofy boasts of being India’s largest community of verified doctors. The startup offers a secure and spam-free platform to doctors to communicate with each other. Curofy currently has more than 1-lakh+ active doctors and 500 medical cases being discussed daily on its mobile app.

Since 2016, the startup isn't doing too good in terms of its balance sheet althoug it has reportedly broke even last year.

In 2016-17, Curofy made a mere total revenue of Rs 1.05 crore. This included other income worth Rs 22.6 lakh. The company made a loss of Rs 6.4 crore in the same year. In 2015-16, Curofy had a total income of Rs 7 lakh, according to the financials, filed with the Ministry of Corporate Affairs.

Post this sell out, all three co-founders will continue to run Curofy, at least in the short term, said the VCCircle report.

We have had featured Curofy in August'16 and back then, in one of its future plans, the startup was contemplating association with various top doctors in India specialising in their fields and making them the face of the Curofy mobile app.

In August 2016, Curofy hired former Head of Products of Limeroad, Abhishek Sharma as VP Products, to drive its monetization route.

Later in November 2016, Curofy was even shortlisted to participate in the third batch of Google Launchpad Accelerator programme to be held at Google Headquarters in California, USA.

Moreover, in the same year, Curofy started pilots with major healthcare stake-holders in the industry and pharma giants like GSK, Abbott, Sanofi were onboarded to take advantage of the ever-growing and highly engaged doctor’s community on Curofy. Curofy has also tied up with Philips in another deal that could prove to be crucial going into their growth however what went wrong is still to fiured out, and an official statement from the founders from the startup is needed to clarify the odds the faced which should definitely be a learning for other budding entrepreneurs.

Notably, according to a NASSCOM report published in November 2017 healthcare along with fintech are most funded segments of startups in India, in past one year. The funding in healthcare tech segment has witnessed 129% increase in funding from $70 million in FY17 to $160 million in FY18

Coming back to Curofy's sell out report, we have sent email queries to both Curofy and VC firm RoundGlass Partners, and incase of any update from both we will update this article.

RoundGlass Partners is a Seattle-based venture capital firm that focuses on healthcare technology startups. The company’s other bets in Indian healthcare startups include fitness aggregator Gympik, doctor consultation platform Doctor Insta and digital diabetes management programme Life in Control.

Gurgaon-based Curofy's Investor Buys The Startup From Its Founders

Gurgaon-based doctor networking platform Curofy has been sold out to its investor RoundGlass Partners LLC, from which the startup had raised undisclosed amount of funding in 2016. RoundGlass Partners has now took over Curofy approximately two years after the investment, reported VCCircle, citing two people aware of the development.

The report further said that the parent company of Curofy, 911 India Healthcare Pvt. Ltd, has been sold to RoundGlass in an all-cash deal worth $9-12 million (Rs 60-80 crore).

Founded in 2015 by IIT-Delhi alumni -- Mudit Vijayvergiya, Nipun Goyal and Pawan Gupta, Curofy boasts of being India’s largest community of verified doctors. The startup offers a secure and spam-free platform to doctors to communicate with each other. Curofy currently has more than 1-lakh+ active doctors and 500 medical cases being discussed daily on its mobile app.

Since 2016, the startup isn't doing too good in terms of its balance sheet althoug it has reportedly broke even last year.

In 2016-17, Curofy made a mere total revenue of Rs 1.05 crore. This included other income worth Rs 22.6 lakh. The company made a loss of Rs 6.4 crore in the same year. In 2015-16, Curofy had a total income of Rs 7 lakh, according to the financials, filed with the Ministry of Corporate Affairs.

Post this sell out, all three co-founders will continue to run Curofy, at least in the short term, said the VCCircle report.

We have had featured Curofy in August'16 and back then, in one of its future plans, the startup was contemplating association with various top doctors in India specialising in their fields and making them the face of the Curofy mobile app.

In August 2016, Curofy hired former Head of Products of Limeroad, Abhishek Sharma as VP Products, to drive its monetization route.

Later in November 2016, Curofy was even shortlisted to participate in the third batch of Google Launchpad Accelerator programme to be held at Google Headquarters in California, USA.

Moreover, in the same year, Curofy started pilots with major healthcare stake-holders in the industry and pharma giants like GSK, Abbott, Sanofi were onboarded to take advantage of the ever-growing and highly engaged doctor’s community on Curofy. Curofy has also tied up with Philips in another deal that could prove to be crucial going into their growth however what went wrong is still to fiured out, and an official statement from the founders from the startup is needed to clarify the odds the faced which should definitely be a learning for other budding entrepreneurs.

Notably, according to a NASSCOM report published in November 2017 healthcare along with fintech are most funded segments of startups in India, in past one year. The funding in healthcare tech segment has witnessed 129% increase in funding from $70 million in FY17 to $160 million in FY18

Coming back to Curofy's sell out report, we have sent email queries to both Curofy and VC firm RoundGlass Partners, and incase of any update from both we will update this article.

RoundGlass Partners is a Seattle-based venture capital firm that focuses on healthcare technology startups. The company’s other bets in Indian healthcare startups include fitness aggregator Gympik, doctor consultation platform Doctor Insta and digital diabetes management programme Life in Control.

Curofy to Join Third Google Launchpad Accelerator Programme

Curofy, a verified doctor-networking platform has been shortlisted to participate in the third batch of Google Launchpad Accelerator programme to be held at Google Headquarters in California, USA.

The equity-free programme will begin on January 30, 2017.During each class, over 20 Google teams will provide comprehensive mentoring to late-stage app startups. The three-month programme starts with an all-expenses-paid two-week boot camp at Google headquarters.

The two-week boot camp will start with determining challenges the startups face, providing mentorship and solutions along with Google resources that enable their products/apps to scale.

Apart from Curofy, the six other startups shortlisted from India includes Flyrobe, HashLearn, Rentmojo, KaptureCRM, Happy Adda Studios and Playment.  24 other startups will also join the programme from Brazil, Indonesia, Mexico, Argentina, Colombia, Philippines, Thailand and Vietnam.

Commenting on this opportunity, Pawan Gupta, co-founder, Curofy said, "Google Accelerator provides a great opportunity for Indian startups to be mentored in best product and engineering practices followed in Silicon Valley. The learning and exposure from the accelerator will prepare Curofy's product for its growth beyond India".

Launchpad Accelerator is Google’s premier program for startups developing technical products on Google platforms. The heart of the program is technical training and strategic mentorship, helping developers succeed.

For detailed list of the selected startups Click Here

Curofy Hires Jo Peddhinti from Eli Lilly to Disrupt Pharma Marketing Industry

Curofy, the community of verified doctors has appointed Jo Peddhinti as a Business and Digital Marketing Strategist, with a focus on organizations in pharmaceutical companies, biotechnology firms and donor registries. Jo has seven years of experience in business strategy, digital marketing strategy, tactical planning, cross-channel marketing and market research.

Previously, Jo was at Eli Lilly in India, where she was hired by the affiliate to design a digital transformation plan that would allow Lilly to rapidly accelerate its digital footprint in India. Her digital innovations have been used as best practices by Lilly to accelerate digital transformation across its emerging market affiliates like Thailand, Saudi Arabia etc.

Hiring of Jo comes at a time when Curofy is looking to explore monetization channels by disrupting the pharma marketing industry. Curofy has already run some successful pilots with both Indian and International pharma giants, and has also established strong relationships with other pharma companies. From market research, to drug launch to webinar registration, Curofy is going the whole yard in building an array of offerings for the industry to choose from. It is also notable that the consumer healthcare sector and also other stakeholders like financial services, hopitals are also reaching out to curofy to help them in their digital strategy. What is even more interesting is the fact that even NGOs have touched base with Curofy to explore the synergies possible.

Curofy has started pilots with major healthcare stake-holders in the industry. Pharma giants like GSK, Abbott, Dr Reddy's and Cipla are already onboard to take advantage of the ever-growing and highly engaged doctor’s community on Curofy.

Last month as part of their expansion to walk towards the monetization route, Curofy also hired Abhishek Sharma, ex Limeroad Head of Products as VP Products.

For Pharma companies, the marketing towards doctors takes the brunt of the budget. Right from the very inception of the idea of the drug to the brand perception, customer engagement and social listening could hold the key to arrive at actionable inputs. Digitisation in the industry will bring the offline phenomenon online.

“Pharma marketing is an important aspect of health care sector and with Jo on board we are sure to gain from her invaluable experience and knowledge”, said Mudit Vijayvergiya, co-founder Curofy. "The pharma market is looking to go digital as evident from the flurry of pilot projects that we presently doing,Jo's industry knowledge will help gauge the needs of the industry." He added.

Jo has a Masters degree in biological sciences from BITS Pilani and an MBA from Simon School of Business in Rochester, New York. She is passionate about reinventing healthcare customer engagement through technology and believes in mobile health, multichannel marketing, physician social networks and digital transformation strategies for pharmaceutical industry.

Limeroad Head of Product Joins Curofy to Walk the Monetization Route

Curofy, the largest community of verified doctors has appointed former Head of Products Limeroad, Abhishek Sharma as VP Products.  As a seasoned campaigner, he has been a part of the start up ecosystem right from his early days at Flipkart. An IIT Delhi graduate rose up the ranks from a founding member of its technology team to become the Head of Products at Limeroad and has played a pivotal role in their success.

Abhishek has also tried his hand at entrepreneurship for a brief span of time when he started Offerbean.com, an eCommerce marketplace platform in 2011. With Abhishek in the team, the co-founders firmly believe that Curofy can certainly monetise their business without affecting the user experience.

Curofy has started pilots with major healthcare stake-holders in the industry.  Pharma giants like GSK, Abbott, Sanofi are already onboard to take advantage of the ever-growing and highly engaged doctor’s community on Curofy.  Curofy has also tied up with Philips in another deal that can prove to be crucial going into their next phase of growth.

Apart from the big names, various smaller firms have reached out to Curofy in order to get doctors on board economically. The projects range from product launches to webinar campaigns to brand recall to hard sales. The market for digital marketing of pharma products, medical devices, medical recruitment and medical content is expected to reach to north of US$1bn in India by 2021.

“The sheer range of projects the industry is coming up with is testimony of the potential they see in us.” says Pawan Gupta, co-founder, Curofy. “These pilots will also help us in zeroing in the best monetization paths for us.” he adds.  As the co-founder puts it, so far so good till now. “The industry is looking to go digital. They have identified companies Curofy as a viable channel. This poses a serious challenge, as it has not been before. And we are definitely up for it”.

In a time when the medical industry as whole is looking to cut down marketing budgets not only because of rising competition but also because of various government regulations. Hence digital has emerged as viable option for the industry to mobilise their target audience. Incidentally, this movement is turning out to be a global phenomenon. As it turns healthcare industries all over the world were facing inefficiencies of some kind, which they are actively trying overcome. Hence Curofy is venturing into pilots in certain countries where the time seems right.

Curofy has started its pilots in countries like UAE, Lebanon, Turkey and Saudi Arabia. "The pilots were mainly to judge the markets in these countries. Though language has been a palpable barrier, we have received pretty great response especially from Turkey where the market is very similar to that of India’s.", says Gupta.

Curofy wants to make the doctors more efficient every day. And if they can solve the industries problem and yet keep the experience of the doctors intact, they would go a long way towards achieving their ambitious dream. They have weathered the storm. They now need to ride the wave. And with a team comprising of the best of talents available today, the dream is certainly on.

How Three IIT-Delhi Alumni Created India's Largest Community of Verified Doctors.

Doctors are someone whom we trust with our lives and the lives of our loved ones. Wouldn't it be great if we could have all the doctors under one roof? Well, solving this doctors dilemma is a Gurgaon based startup called Curofy.

What is Curofy?

Boasting to be India's largest community of verified doctors, Curofy has been conceived with the sole objective of bridging the currently visible gap among doctors and help them collaborate easily with each other to solve various medical cases.

By offering a secure and spam-free platform to doctors to communicate with each other, Curofy currently has more than 30000 active doctors and 150 medical cases being discussed daily on the Curofy app.



Using the app, doctors can share cases with each other, call each other without saving numbers and provide referrals to one another. Not only this, using the app, the user will also have access to all the latest developments happening in various medical fields, thus transforming the platform into a collaborative learning one.

With the medical field evolving everyday with new diseases, new cures and new technology, practicing professionals find it a tough task to keep pace with these developments but with Curofy, all this is soon going to be a thing of the past.

How did the journey begin?

The idea for Curofy stuck the three founders mind during a midnight coffee break in the last year of college. With the entrepreneurial bug bitten, the three decided to first research well and then take the final plunge. After graduation, they stuck with good paying MNC jobs, while simultaneously researching and meeting doctors. Once they were fully sure about the concept, they left their jobs and joined hands to give life to Curofy.

USP of the Startup

According to Curofy, being a mobile only platform has proved to be a big plus point for them as it helps them provide their users with a sorted, clutter free environment- something which is a far cry from their busy and complex professional lives. The ease with which the doctors can network with one another is something which no other platform has been able to achieve in the past.

The Founders

Mudit Vijayvergiya, Nipun Goyal and Pawan Gupta are the three genius behind the startup. Belonging to the same college, IIT Delhi, Mudit is a dual degree graduate in chemical engineering, Nipun is a B.Tech from with major in Electrical Engineering and minor in Business Management and Pawan is a B.Tech. in Electrical Engineering.

Funding Details

On the funding front, all is well with Curofy. Having started its funding journey in the reality television-type formatted Young Turks TiE the Knot at TiEcon in October 2014, the startup managed to raise $150,000 owning to great interest from various investors post the event. Recently, the startup industry was abuzz with the news of Curofy raising an undisclosed amount for their pre-series A funding from a Round Glass partners, a US based VC firm.

Big industry names like Rajul Garg (Sunstone Business School, Global Logic, Pine Labs), Alok Mittal (JobsAhead, Canaan), India Quotient, Spice Labs, Dinesh Agarwal (Indiamart), Dr Shuchin Bajaj (Cygnus Hospitals), and Presha Paragash (Zostel, Sol Primero) have invested their trust and money in the company.

Future Plans of the startup

Curofy's immediate plans are to make their app more personalised and offer their users with an even better experience. In addition to this, they wish to keep improving their product and become the best friend of every doctor in town. Further, the startup is also contemplating associating with various top doctors specialising in their fields and making them the face of the Curofy app.

Curofy app is for sure a breath of fresh air in the Indian healthcare field, opening new avenues for digital health by increasing online activity of doctors.